DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification

Stock Information for Diagnos Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Diagnos Inc.

DIAGNOS Announces Closing of First Tranche of Private Placement
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing
AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
DIAGNOS Announces Grant of Stock Options
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.